Patient Guide: Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 51 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05877963
Status: 🟢 Enrolling Now
Condition: Relapsing Multiple Sclerosis
Phase: Phase III

Find a Study Location Near You

This study is available at 51 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Birmingham, Alabama
  • • Cullman, Alabama
  • • Orange, California
  • • And 48 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab - Join Clinical Trial NCTNCT05877963

How to Join This Clinical Trial - NCTNCT05877963

Learn how to participate in this Phase III trial studying an investigational therapy for Relapsing Multiple Sclerosis. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsing Multiple Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsing Multiple Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
Phase III - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05877963 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 51 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: RECRUITING

Clinical Research Site

Cullman, Alabama 35058 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92697 - United States

Status: RECRUITING

Clinical Research Site

Fort Collins, Colorado 80528 - United States

Status: RECRUITING

Clinical Research Site

Washington D.C., District of Columbia 20007 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33612 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30309 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Savannah, Georgia 31406 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60612 - United States

Status: RECRUITING

And 41 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase III clinical trial for Relapsing Multiple Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation